Quantcast

Targeted Agent Shows Promise for Chornic Lymphoid Leukemia

September 14, 2010

James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have identified an experimental agent that targets chronic lymphocytic leukemia and perhaps other proliferative disorders of lymphocytes. credit: OSU



comments powered by Disqus